Groupe Hospitalier Bretagne Sud

Lorient 56322

0 studies enrolling now · 2 studies all time

What they study most

NSCLC, Nonsmall Cell Lung Cancer, Urothelial Cancer

Studies at this site

• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) — Completed